U.S. federal agency safeguarding public health through food and drug oversight
The FDA has required makers of GLP‑1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, to add a warning about a rare eye condition called non‑arteritic anterior ischemic optic neuropathy (NAION). The agency has found a small increased risk in trial and real‑world data and is urging patients with sudden, painless vision loss in one eye to seek prompt ophthalmology evaluation.
The Democratic Republic of Congo has recorded an unprecedented Bundibugyo Ebola outbreak that has spread across six provinces and produced more than 5,000 confirmed cases and over 2,600 deaths. WHO and partners have allocated 70,000 Ervebo vaccine doses—20,000 for a Phase III trial and 50,000 for frontline workers—while CEPI has funded a Bundibugyo-specific vaccine and the US has sent MBP134 treatment vials to Uganda.
Major US medical societies have issued unified guidance this week for flu, COVID-19 and RSV vaccines after the CDC’s advisory process has been disrupted. Updated COVID shots have FDA approval and manufacturers are shipping doses, but legal and policy disputes over federal recommendations continue to leave states and insurers uncertain about timing and coverage.
The Corte Madera Town Council votes to advance an ordinance banning tobacco and nicotine products, including vapes, with a transition through Jan. 31, 2027. Residents may keep possessions. Public comment highlighted concerns from students and families affected by tobacco-related illness.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
Investors have pushed new biotech winners — from Novo Nordisk’s semaglutide pill to startups tackling baldness and targeted autoimmune drugs — while market enthusiasm has cooled for some forecasts. Novo Nordisk has released a daily weight‑loss pill used by over 1.5 million people; hair‑loss startups have sent small caps soaring; India’s low‑cost GLP‑1 generics have underperformed expectations.
Several women in Africa and the UK face long waits for fibroid treatment and endometriosis diagnosis, highlighting delays in access to care, testing, and surgical options. New tests abroad offer hope, but are not yet widely available in the US.
The US Centers for Disease Control and Prevention has declared the multistate cyclospora outbreak tied to iceberg lettuce over after cases have fallen sharply. Federal investigators have linked the outbreak to iceberg lettuce imported from central Mexico by Taylor Farms; about 12,800 people were infected, 570 were hospitalised and two people died.
A synthesis of recent sleep studies shows wearables may misjudge sleep quality, narcolepsy treatment advances gain regulatory traction, and weekend catch-up sleep ties to lower hypertension risk, prompting a nuanced view of how to monitor and improve sleep.
Flu vaccines are underway and updated COVID-19 shots are arriving nationwide after FDA approval. RSV remains a threat, prompting guidance from medical societies as Trump health officials rethink autumn vaccine policies. An advisory panel remains in a legal dispute, while doctors push clear, science-based guidance. Older adults and high-risk groups are urged to vaccinate, with a new mRNA flu shot showing improved effectiveness.
West has initiated an emergency appeal to halt a California court order recognizing Omar Ahmed and Nausheen Gilkar as the baby’s parents. West seeks custody or conservatorship to ensure life-saving treatment for the infant born with hypoplastic left heart syndrome. The case highlights surrogacy, abortion, and interstate medical-care disputes.
The FDA has cleared four blood tests to help diagnose Alzheimer's in people with memory problems, a move that could speed access to therapies. Experts caution that tests are not for asymptomatic individuals, and many questions remain about accuracy. Readers are advised to focus on brain-healthy risks like blood pressure, diabetes and smoking.
The administration has moved to align U.S. Medicare drug prices with those in other wealthy countries, a shift that could affect pharmaceutical profits and patient access. Bloomberg reports two related developments: price alignment for Medicare and overall U.S. pricing pressure as manufacturers weigh their U.S. market strategies.
The Department of Justice has reached a settlement with Abbott over concerns about a Michigan plant that produced a major share of the U.S. infant formula supply. Regulators cite unsanitary conditions; Abbott reports no admission of fault and notes negative tests on unopened product from infants’ homes. The deal directs corrective steps and allocates funds to regulators and whistle-blowers.
Saphier has been nominated to serve as surgeon general. She is navigating questions about vaccine policy, credentials, and potential conflicts of interest as lawmakers scrutinize her readiness to lead public health messaging.
A three‑judge panel of the 1st US Circuit Court of Appeals has largely upheld a lower court ruling that found the Department of Homeland Security’s third‑country removal policy unlawful, saying migrants must get a meaningful chance to raise safety concerns before removal. The panel narrowed one part of the decision on procedural grounds. The administration is expected to appeal.
Novo has laid out a plan to diversify beyond Wegovy and Ozempic as it faces looming exclusivity losses. Capital Markets Day signals a push into cardiovascular, liver and blood disorders with a target to expand its pipeline, while investors question credibility and near-term milestones amid a evolving GLP-1 landscape dominated by Lilly.
Influencer Braden Peters, known online as Clavicular, has been charged in Massachusetts with rape, providing liquor to a minor, and drugging for sexual intercourse, linked to an alleged May 2025 incident on Cape Cod. A separate Florida civil suit accuses him of coercion and non-consensual procedures. Peters denies the accusations and faces further legal proceedings.
Two Ole Miss students have died in separate locations. Authorities say kratom was found at the scenes, but there is no confirmed information that kratom contributed to either death. Investigations are ongoing; toxicology reports are being expedited.
Lawsuits allege GLP-1 diabetes drugs may cause nonarteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause permanent vision loss. Novo Nordisk and Eli Lilly dispute the claims as regulators review data; meanwhile trials and studies show mixed signals about risk.
The Speaker is campaigning across multiple states to defend Republican-held seats while pursuing a broader message on cost of living and reform. The push follows a six-week sprint across 20 states, with a focus on key battlegrounds as November nears.
A recall first issued in July has expanded to include more frozen berry products tied to an E. coli outbreak that has infected at least 17 people across Florida and Georgia. The FDA warns consumers to discard affected products and seek refunds. Public health officials say the outbreak, now linked to Frutas y Hortalizas del Sur S.A., has prompted recalls across retailers including Walmart and Trader Joe’s.
The FDA has closed its investigation into the Taylor Farms cyclospora outbreak linked to lettuce. Investigators found cyclospora in a wastewater tank and a drainage ditch at the Taylor Farms site in Guanajuato, Mexico, but the agency says it is unclear how contamination occurred. The outbreak had caused nearly 13,000 illnesses across the United States.
The Supreme Court is evaluating whether federal law preempts state and local lawsuits accusing oil companies of climate-related damages. Boulder, Colorado, leads a wave of cases seeking damages for disaster costs, with ExxonMobil and Suncor among the defendants. The decision could affect dozens of similar lawsuits nationwide.
PepsiCo has initiated a class II recall after undeclared Yellow No. 5 and/or No. 6 dyes were found in several Gatorade flavors. The recall covers 28-ounce bottles distributed across 37 states. Consumers are advised not to drink affected products and to seek refunds; the FDA classifies the risk as mid-level.
A federal lawsuit in Seattle accuses Starbucks of labeling eight protein drinks as sugar-free while containing 13–21 grams of sugar per venti, prompting questions about added vs. total sugar and FDA labeling rules. Starbucks denies wrongdoing and says the sugar comes from lactose in milk.
The Justice Department has reached a settlement with CVS over a 2024 lawsuit that accused the company of dispensing large quantities of opioids and other controlled substances to fuel profits, sidelining public health. The agreement requires additional safeguards to ensure prescriptions are medically appropriate, with no admission of wrongdoing by CVS.
The administration has moved to allow some popular, yet unproven, injectable peptides to be temporarily manufactured by specialty pharmacies. The plan, still subject to White House review, would use enforcement discretion to avoid immediate enforcement of current restrictions, while a formal rulemaking process could take years.
Means has left his White House role amid tensions within the Make America Healthy Again movement over progress on food reform, vaccine policy and industry pushback. The departure follows slow progress on ultraprocessed-food definitions and related health initiatives in Kennedy’s agenda.
The White House has reviewed a policy directed at peptides used in wellness, after pushback from FDA scientists warning it could undercut safety. Kennedy’s HHS pushed a plan to curb enforcement against compounding pharmacies that sell peptides like BPC-157 and TB-500, with comments invited for two weeks.
Researchers have chemically confirmed preserved heme in a 115-million-year-old Aratasaurus museunacionali bone, suggesting hemoglobin-derived molecules can endure deep time under manganese-stabilized fossilization. The finding, published in Proceedings of the National Academy of Sciences, challenges assumptions about fossil soft-tissue preservation and opens new avenues for studying ancient biology and possibly life beyond Earth.
England launches STRIDE-RCT, a government-funded trial offering blood-based tests to 45-plus patients at about 200 GP surgeries to detect abdominal cancers early. The study will assess accuracy and determine if tests can guide urgent investigations for prostate, ovarian, bowel, pancreatic, stomach, liver and other cancers.
Anthropic has filed its S-1 ahead of a major IPO, presenting a life-sciences vision for AI. The company highlights Claude as a catalyst for rapid biological progress, backed by partnerships with pharma giants and a Bay Area biology lab. Industry skepticism remains about cures and clinical realities, even as AI accelerates drug discovery.
Trump-era health policy tensions spill into public view as Calley Means alleges internal interference by Susie Wiles and others, while new chief of staff Stephen Miller signals a shift. The feud raises questions about who is guiding the Make America Healthy Again agenda and what that means for policy and politics.
The FDA has required safety labeling for GLP-1 receptor agonists, warning of a potential link to non-arteritic anterior ischemic optic neuropathy (NAION). While NAION is rare, the agency says cases have been reported and risk factors overlap with patients using GLP-1 therapies. Health providers are urged to monitor for painless vision loss and refer promptly to ophthalmology if suspected.